Primary localised prostate cancer research hub

Open-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System and verteporfin for injection for the treatment of primary localized prostate cancer

This study is testing a new way to treat prostate cancer that hasn't spread. It uses a special light treatment and a drug called Visudyne. Doctors want to see how safe it is and how well it works to remove cancer cells.